Third Party Observations at the EPO
Read more >
Featured Insights: inventive step
Relying on post-filed data when arguing inventive step before the EPO?
Read more >
Patenting artificial intelligence and neural networks in Germany
Read more >
Getting your facts straight at the EPO
Read more >
A primer on patenting artificial intelligence in Europe
Read more >
Breaking News – Update on G 1/19 Simulation Referral to Enlarged Board of Appeal
Read more >
Regeneron v Kymab – Sufficiency explained through transgenic mice and teleporters
Read more >
Public availability at confidential technical standards committees
Read more >
Lost in translation: Are animal models predictive of a treatment effect?
Read more >